These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1565 related articles for article (PubMed ID: 29717790)

  • 1. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors.
    Zhang J; Chen Y; Zhang E; Li N; Yuan H; Lang N
    Eur Spine J; 2020 May; 29(5):1112-1120. PubMed ID: 32040617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.
    Park VY; Kim SG; Kim EK; Moon HJ; Yoon JH; Kim MJ
    Magn Reson Imaging; 2019 Oct; 62():199-208. PubMed ID: 31323316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
    Cheng J; Shao S; Chen W; Zheng N
    J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions.
    Liu W; Wei C; Bai J; Gao X; Zhou L
    Eur J Radiol; 2019 Aug; 117():156-163. PubMed ID: 31307642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
    Liu C; Wang K; Chan Q; Liu Z; Zhang J; He H; Zhang S; Liang C
    Eur Radiol; 2016 Nov; 26(11):3888-3898. PubMed ID: 26863896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XGboost Prediction Model Based on 3.0T Diffusion Kurtosis Imaging Improves the Diagnostic Accuracy of MRI BiRADS 4 Masses.
    Tang W; Zhou H; Quan T; Chen X; Zhang H; Lin Y; Wu R
    Front Oncol; 2022; 12():833680. PubMed ID: 35372060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion kurtosis imaging does not improve differentiation performance of breast lesions in a short clinical protocol.
    Palm T; Wenkel E; Ohlmeyer S; Janka R; Uder M; Weiland E; Bickelhaupt S; Ladd ME; Zaitsev M; Hensel B; Laun FB
    Magn Reson Imaging; 2019 Nov; 63():205-216. PubMed ID: 31425816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogram analysis of diffusion kurtosis imaging based on whole-volume images of breast lesions.
    Li T; Hong Y; Kong D; Li K
    J Magn Reson Imaging; 2020 Feb; 51(2):627-634. PubMed ID: 31385429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
    Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
    Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
    Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
    J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.